Article
Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via…
Journal of Inflammation Research · 2024 · Guo R, Liao H, Meng Y, Shi X, He Y, Zhu Z, Guo W
Key facts
| Title | Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways |
|---|---|
| First author | Guo R, Liao H, Meng Y, Shi X, He Y, Zhu Z, Guo W |
| Journal | Journal of Inflammation Research |
| Published | Nov 25, 2024 |
| DOI | 10.2147/JIR.S486753 |
| Devices mentioned | K041074, K843077, K843710 |
| Product codes mentioned | DGC, GKZ, LGC, MVU, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1